HEALTH● LOWAug 14 · Aug 14, 2026, 7:29 AM
U.S. FDA issues warning letter to Aurobindo Pharma’s subsidiary Eugia Pharma
The Hindu
A formulation manufacturing unit of subsidiary Eugia Pharma Specialities near Hyderabad had earlier received four observations and an Official Action Indicated (OAI) status from the regulator
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH41m agoNAFDAC orders recall of sachet alcohol drinks below 200mlVanguard NigeriaHEALTH56m agoLucía Kazelian, cardiologist: "Cardiovascular disease in women is not the same as in men"ClarínHEALTH1h agoRed hexagon on your snack pack: What FSSAI’s new proposed warning label means | ExplainedThe HinduHEALTH3h agoRotten meat, spoiled milk seized across Bengal as food safety raids widenThe Hindu